// App-Quantinova.ai

1955 : Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma

Researchers

Presenter

  • Angelique Boyer

Principal Investigators

  • Adriana C Rossi

  • Selina Chen-Kiang

  • Ruben Niesvizky

  • Dennis Kwon

  • Roger N Pearse

  • Faiza Zafar

  • Karen Pekle

  • Linda Tegnestam

  • David Jayabalan

  • Scott A Ely

  • Morton Coleman

Medical Centers

  • Department of Pathology & Laboratory Medicine, Weill Cornell Medical College, New York, NY

  • Center of Excellence for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY

  • Weill Cornell Medical College, New York, NY

  • Hematology/Oncology, Weill Cornell Medical College, New York

  • Department of Pharmacology, Weill Cornell Medical College, New York, NY

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Congestive heart failure

  • Peripheral neuropathy

  • Pulmonary embolism

  • Neutropenic Sepsis

  • Venous thrombosis

  • Multiple Myeloma

  • Thrombocytopenia

  • Neutropenia

  • Anemia

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Biaxin

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • Bortezomib

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved